BD PROJECTS

• Product for Licensing

  【Asset for Licensing】Oral small-molecule PD-L1 inhibitor for solid tumor treatment

  2026年7月9日
• Product for Licensing

  【Asset for licensing】LY6G6D-targeting antibodies for advanced malignant solid tumors

  2026年7月9日
• Product for Licensing

  For Licensing: Multi-Target Oral Brain-Penetrable Small Molecule for ASD, High Selectivity & High Binding Affinity

  2026年7月8日
• Product for Licensing

  Asset for Licensing: 11β-HSD1 Inhibitor, Oral QD candidate for MASH & IPF indications

  2026年7月8日
• Request for Product

  Great Out-Licensing Opportunity for Biosimilars!

  2026年7月8日
• Request for Product

  Listed Chinese pharma seeks clinical-stage innovative drugs for gynecology (non-oncological) and anti-infection; small molecules preferred

  2026年7月8日
• Request for Product

  Global top pharma and VCs seek in vivo CGT platforms and therapeutic programs for for thalassemia and sickle cell anemia

  2026年7月8日
• Request for Product

  Seeking innovative oral small molecules for innate immunity, indications: inflammatory & immune diseases

  2026年7月8日
• Request for Product

  Licensing needs from European and US pharmaceutical enterprises & venture capital firms

  2026年7月8日
• Product for Licensing

  Probiotic Vaccine Platform Seeking Collaboration Partners

  2026年7月8日